Pervasive Sensing and Artificial Intelligence in Intelligent ICU Subtitles: -Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making -ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention
Sponsor: University of Florida
Trial Details
| Condition | Critical Illness, Pain, Delirium, Confusion |
| Intervention | Video Monitoring; Accelerometer Monitoring; Noise Level Monitoring; Light Level Monitoring; Air Quality Monitoring; EKG Monitoring; Vitals Monitoring; Biosample Collection; Delirium Motor Subtyping Scale 4 (DMSS-4) |
| Status | Recruiting |
| Participants | 400 |
| Est. Completion | 1 Dec 2026 |
| Last Updated | 6 July 2026 |
Primary Outcome
Algorithmic Activity Labeling; Algorithmic Pain Labeling; Decibel Levels; Lux Levels; Air Quality; Circadian Dyssynchrony Index; Algorithmic Delirium Recognition Profile; Delirium Motor Subtyping Scale 4 (DMSS-4)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * aged 18 or older * admitted to UF Health Shands Gainesville ICU ward * expected to remain in ICU ward for at least 24 hours at time of screening Exclusion Criteria: * under the age of 18 * on any contact/isolation precautions * expected to transfer or discharge from the ICU in 24 hours or less * unable to provide self-consent or has no available proxy/LAR
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service